Allogene Therapeutics, Inc. · NASDAQ:ALLO

David D. Chang, M.D., Ph.D.'s stake in Allogene Therapeutics, Inc. fell to 4.90% (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 13, 2026

David D. Chang, M.D., Ph.D.'s stake in Allogene Therapeutics, Inc. fell to 4.90%, 12,297,354 shares, as a passive investor on Mar 31, 2026. Filed May 13, 2026 (Schedule 13G/A).

Stake
4.90%
Shares
12,297,354
Intent
Passive
What changed
Fell below 5%
Filed together
4 holders

The filing in full

HolderStakeShares
David D. Chang, M.D., Ph.D.4.90%12,297,354
Chang 2006 Family Trust0.50%1,201,108
JEC 2019 Trust0.30%856,044
RTC 2019 Trust0.30%856,044

Source

View original at SEC

Related